From: Breast cancer subtype predictors revisited: from consensus to concordance?
Dataset | Chip | Nr. of samples | Nr. of samples (%) | Â | |||
---|---|---|---|---|---|---|---|
 |  | after QC | CS | Basal | HER2 | LumA | LumB |
Bos | hgu133plus2 | 188 | 119 (63.3) | 49 (41.2) | 19 (16.0) | 23 (19.3) | 28 (23.5) |
expO | hgu133plus2 | 333 | 213 (64.0) | 56 (26.3) | 20 (9.4) | 75 (35.2) | 62 (29.1) |
Guedj | hgu133plus2 | 501 | 235 (46.9) | 40 (17.0) | 21 (8.9) | 88 (37.4) | 86 (36.6) |
Li | hgu133plus2 | 109 | 83 (76.1) | 25 (30.1) | 10 (12.0) | 29 (34.9) | 19 (22.9) |
Sabatier | hgu133plus2 | 242 | 162 (66.9) | 63 (38.9) | 15 (9.3) | 40 (24.7) | 44 (27.2) |
Total | Â | 1373 | 812 (59.1) | 233 (28.7) | 85 (10.5) | 255 (31.4) | 239 (29.4) |